Olivier CHARMEIL

Olivier Charmeil is a graduate of HEC (Ecole des Hautes Etudes Commerciales) and of the Institut d’Etudes Politiques in Paris. He began his career in the Mergers & Acquisitions department of Banque de l’Union Européenne. He joined Sanofi in 1994 where he has held various positions including Attaché to the Chairman, Jean François Dehecq, before being appointed as VP Development Sanofi Synthélabo International Operations where he was responsible for China and support functions. 
In 2003, he was appointed Chairman and CEO of Sanofi Synthélabo France, before taking the position of SVP Business Management and Support within the Pharmaceutical Operations where he piloted the operational integration of Sanofi Synthélabo and Aventis. In 2006, he was appointed SVP Asia/Pacific & Japan Pharmaceutical Operations and in 2011 EVP Vaccines and became a member of the Executive Committee.
Since 2016, he is Executive Vice President & General Manager, General Medicines and Emerging Markets, Sanofi.